Pfizer Inc (PFE): Today's Featured Drugs Winner
The
industry closed the day up 1.3%.
(
),
(
),
(
), and
(
) were all winners today within the drugs industry with
(
) being today's featured drugs winner. Pfizer Inc rose 41 cents (2.2%) to $19.28 on light volume. Throughout the day, 36.7 million shares of Pfizer Inc exchanged hands as compared to its average daily volume of 53.3 million shares.
Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. Pfizer Inc has a market cap of $151 billion and is part of the
sector. The company has a P/E ratio of 18.1, above the average drugs industry P/E ratio of 17.9 and above the S&P 500 P/E ratio of 17.7. Shares are up 7.8% year to date as of the close of trading on Tuesday.
TheStreet Ratings rates Pfizer as a
. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins, solid stock price performance and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Pfizer Ratings Report.
On the negative front,
(
),
(
),
(
), and
(
) were all losers within the drugs industry with
(
) being today's drugs industry Loser Spotlight stock.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider
(
) while those bearish on the drugs industry could consider
ProShares UltraShort Nasdaq Biotech
(
).
- Find other investment ideas from our top rated ETFs lists.
null
